Updated

Evvy, a women's health company focused on vaginal microbiome testing and research, announced a $40 million Series B funding round led by Catalio Capital Management. The company aims to use its data platform to advance scientific understanding of the vaginal microbiome's role in women's health. The funding reflects growing investor interest in women's health technology and diagnostics, an area historically underfunded relative to other areas of medical research.